Complement C5 drugs for Myasthenia Gravis
3 tracked Complement C5 drugs in the Myasthenia Gravis race. The class explanation lives on the Complement C5 page; the full indication pipeline across every mechanism is on the Myasthenia Gravis page.
2 approved / phase 41 Phase 3
Head-to-head evidence: Cemdisiran vs Eculizumab · Eculizumab vs Ravulizumab